Correlation Between Rigel Pharmaceuticals and ChitogenX

Can any of the company-specific risk be diversified away by investing in both Rigel Pharmaceuticals and ChitogenX at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rigel Pharmaceuticals and ChitogenX into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Rigel Pharmaceuticals and ChitogenX, you can compare the effects of market volatilities on Rigel Pharmaceuticals and ChitogenX and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rigel Pharmaceuticals with a short position of ChitogenX. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rigel Pharmaceuticals and ChitogenX.

Diversification Opportunities for Rigel Pharmaceuticals and ChitogenX

-0.59

Correlation Coefficient

Rigel Pharmaceuticals  ChitogenX

Excellent diversification

The 3 months correlation between Rigel and ChitogenX is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Rigel Pharmaceuticals and ChitogenX in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ChitogenX and Rigel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rigel Pharmaceuticals are associated (or correlated) with ChitogenX. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ChitogenX has no effect on the direction of Rigel Pharmaceuticals i.e., Rigel Pharmaceuticals and ChitogenX go up and down completely randomly.

Pair Corralation between Rigel Pharmaceuticals and ChitogenX

Given the investment horizon of 90 days Rigel Pharmaceuticals is expected to generate 13.96 times more return on investment than ChitogenX. However, Rigel Pharmaceuticals is 13.96 times more volatile than ChitogenX. It trades about 0.35 of its potential returns per unit of risk. ChitogenX is currently generating about -0.12 per unit of risk. If you would invest  1,420  in Rigel Pharmaceuticals on September 2, 2024 and sell it today you would earn a total of  1,341  from holding Rigel Pharmaceuticals or generate 94.44% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	95.45%
Values	Daily Returns

Rigel Pharmaceuticals  vs.  ChitogenX

Rigel Pharmaceuticals

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Rigel Pharmaceuticals are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating technical and fundamental indicators, Rigel Pharmaceuticals disclosed solid returns over the last few months and may actually be approaching a breakup point.

ChitogenX

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ChitogenX has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Rigel Pharmaceuticals and ChitogenX

The main advantage of trading using opposite Rigel Pharmaceuticals and ChitogenX positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rigel Pharmaceuticals position performs unexpectedly, ChitogenX can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ChitogenX will offset losses from the drop in ChitogenX's long position.

The idea behind Rigel Pharmaceuticals and ChitogenX pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.